ANTE--PARTUM. Lecture 3. Antepartum YESSSSSS Antepartum Flashcards
HIGH-RISK PREGNANCY
A pregnancy in which the life or health of the mother or fetus is compromised.
It can be coincidental or unique to pregnancy
Risk Factors during pregnancy
Biophysical
Psychosocial
Socio-demographic
Environmental
Antepartum Testing. When ?
To detect potential fetal compromise
32-34 weeks until delivery
Used primarily for women at risk for disrupted fetal oxygenation
BIOPHYSICAL ASSESSMENTS
Daily Fetal Movement Count (Kick Count):
The daily fetal movement count, often referred to as kick count, is a simple and non-invasive method for pregnant individuals to monitor their baby’s activity level in the womb. It involves keeping track of the number of times a baby moves or kicks within a specific time period, typically over the course of a day. This assessment is important because reduced fetal movements can sometimes indicate potential problems, such as fetal distress or decreased oxygen supply. Healthcare providers may recommend different guidelines for the number of movements that should be felt within a certain time frame, and any significant deviation from these guidelines might warrant further evaluation.
Ultrasound:
Ultrasound is a common prenatal diagnostic tool that uses sound waves to create images of the developing fetus and the mother’s reproductive organs. It provides valuable information about the baby’s growth, position, anatomy, and overall health. Ultrasounds can be performed at different stages of pregnancy, including the first trimester, second trimester, and third trimester. They are used to confirm pregnancy, estimate gestational age, identify multiple pregnancies, monitor fetal growth, check for abnormalities, and assess various other aspects of fetal development. Ultrasound technology has advanced significantly over the years, allowing for detailed and real-time visualization of the fetus.
Biophysical Profile (BPP):
The biophysical profile is a comprehensive assessment used to evaluate the well-being of a fetus during the third trimester of pregnancy. It combines multiple components to provide a more holistic picture of fetal health. The components typically include:
Fetal Heart Rate Monitoring: This involves assessing the baby’s heart rate using a Doppler device or electronic fetal monitor.
Fetal Breathing Movements: Observation of rhythmic breathing movements by the fetus.
Fetal Movement (Body Movements): Similar to the daily kick count, this component evaluates the fetus’s gross body movements.
Amniotic Fluid Volume: Ultrasound is used to measure the amount of amniotic fluid surrounding the fetus. Adequate amniotic fluid levels are important for fetal protection and development.
Fetal Muscle Tone: This component assesses the presence and quality of fetal muscle tone.
Each component is assigned a score, and the cumulative score is used to assess the overall well-being of the fetus. A low score might indicate a need for further evaluation or intervention.
Get to know your baby’s movements and report any change to your MD, CNM or Healthcare Provider
Fetal Movement Counts: Pay attention to your baby’s movement patterns. As your pregnancy progresses, you’ll likely notice a regular pattern of when your baby is most active. Counting the number of movements within a specific time frame, often referred to as a “kick count,” can help you monitor your baby’s activity.
Changes in Movement: If you notice a sudden change in your baby’s movement pattern, such as a significant decrease in movement or a lack of movement for an extended period, it’s important to contact your healthcare provider. Changes in movement could indicate potential issues that need to be evaluated.
Communication with Healthcare Provider: Always communicate any changes in your baby’s movements to your healthcare provider, whether it’s a decrease in movement, an increase in movement, or any other changes that concern you. Your healthcare provider will be able to guide you on whether further assessment is needed.
Monitoring Tools: Some healthcare providers might recommend using specific tools, such as a kick count chart or mobile apps, to help you track your baby’s movements. These tools can provide a structured way to monitor your baby’s activity.
Importance of Monitoring: Monitoring fetal movements is especially important during the third trimester when your baby’s movements become more pronounced. However, it’s generally a good practice to pay attention to movements throughout your pregnancy.
- Ultrasound: can be abdominal (Later stages)or transvaginal (inside vagina, used in early staged coz it’s more precise accurate since it’s closer to the reproductive organs )
Abdominal Ultrasound:
Procedure: In abdominal ultrasound, a handheld device called a transducer is moved over the skin of the abdomen. A gel is applied to the skin to help transmit the sound waves and improve image quality.
Application: Abdominal ultrasounds are commonly used to examine the organs and structures within the abdominal cavity, such as the liver, gallbladder, kidneys, pancreas, spleen, and aorta. It’s also frequently used for pregnancy imaging, especially in the later stages.
Advantages: Non-invasive, does not require any insertion into the body. Can provide a broad overview of abdominal structures.
Transvaginal Ultrasound:
Procedure: In transvaginal ultrasound, a specially designed transducer is inserted into the vagina. This allows for closer proximity to the pelvic organs and structures.
Application: Transvaginal ultrasounds are primarily used to examine the reproductive organs, such as the uterus and ovaries. They are especially useful for early pregnancy imaging, assessing gynecological conditions, and evaluating pelvic pain or abnormal bleeding.
Advantages: Offers higher-resolution images of the pelvic organs due to the closer proximity of the transducer. Provides clearer images, especially in early pregnancy.
Transvaginal ultrasound
- Transvaginal used mainly in in the first trimester - provides greater detail and can dx IUP and establish GA earlier
- Levels of ultrasonography:
**Standard – GA, AFI’s etc.
**Limited – e.g., check for vertex presentation, FHR
**Specialized- suspected anatomical or physiological abnormal fetus
You’re absolutely right, transvaginal ultrasound is often used in the first trimester of pregnancy and provides higher resolution images that can aid in diagnosing various conditions, including confirming an intrauterine pregnancy (IUP) and establishing gestational age (GA) more accurately. The ability to get closer to the reproductive organs through the vaginal approach allows for more precise measurements and imaging during this early stage of pregnancy.
Regarding the levels of ultrasonography you mentioned, you’ve provided an accurate breakdown of the different types:
Standard Ultrasonography:
This is a comprehensive ultrasound examination that includes assessing various aspects of pregnancy. It can involve measurements of gestational age, amniotic fluid levels (AFL), and the general well-being of the fetus. Standard ultrasonography is often used to monitor the overall progress of the pregnancy and the health of the developing fetus.
Limited Ultrasonography:
Limited ultrasound exams focus on specific aspects of the pregnancy. They are often done for targeted purposes, such as checking for fetal heart rate (FHR) or confirming the fetal presentation (e.g., vertex presentation) to ensure proper positioning for childbirth. These exams are more streamlined and address specific concerns.
Specialized Ultrasonography:
Specialized ultrasounds are used when there are suspected anatomical or physiological abnormalities in the fetus. These exams are more detailed and thorough, aiming to provide in-depth information about specific areas of concern. They are often performed by experts in fetal medicine or specialized ultrasound technicians.
Indications For Use. Ultrasound
- Fetal Heart Activity
- Gestational Age
- Fetal Growth
- Fetal Anatomy
- Fetal Genetic
- Fetal Position
- Disorders and Physical Anomalies
- Placental Position and Function
- Adjunct to other tests
- Fetal Well Being
Ultrasound to Determine Gestational Age
Fetal Growth. Todas estan hechas con ultrasonido
Recommended Method of Dating:
Ultrasound is one of the most accurate methods for determining gestational age during pregnancy. It provides visual information about the fetus’s development, which helps healthcare providers estimate how far along a pregnancy is.
Most Accurate Between 14-22 Weeks:
While ultrasound can be performed at various stages of pregnancy, the most accurate determination of gestational age typically occurs between 14 and 22 weeks. During this period, various fetal structures and measurements can be observed with high precision.
Gestational Sac Dimensions (8 Weeks):
During early pregnancy, around 8 weeks gestation, the dimensions of the gestational sac can provide information about the development of the embryo.
Crown/Rump Length (7-12 Weeks):
The crown-rump length (CRL) measurement is taken from the top of the baby’s head (crown) to the bottom of its buttocks (rump). It’s a reliable indicator of gestational age and is most accurate between 7 and 12 weeks.
BPD (Biparietal Diameter) and Femur Length (12 Weeks):
The biparietal diameter (BPD) is the measurement between the two sides of the baby’s head. It’s commonly used to estimate gestational age and assess growth. Femur length, the measurement of the thigh bone, is another indicator of fetal size.
Serial Evaluations for Fetal Growth:
Serial evaluations involve tracking the growth of specific fetal measurements over time. This includes monitoring changes in the biparietal diameter, limb length, and abdominal circumference. These measurements are essential to assess how well the fetus is growing and to detect any potential growth abnormalities.
Abdominal Circumference:
Abdominal circumference is an important measurement that reflects the size of the fetal abdomen. It’s used to assess fetal growth and well-being, as abnormalities in abdominal circumference can indicate issues such as intrauterine growth restriction (IUGR).
By combining various measurements taken during ultrasound examinations, healthcare providers can create a comprehensive picture of the fetus’s development, gestational age, and growth trajectory.
Biparietal Diameter (BPD) to determine
Gestational age
After 12 weeks (BPD has 3 letters and 12 weeks = 3 months )
Biparietal etymology
The term “biparietal” is derived from two Latin words: “bi” meaning “two” and “parietal” referring to the parietal bones of the skull. The parietal bones are two of the major cranial bones that form the upper sides and roof of the skull.
In medical and anatomical terminology, “biparietal” is often used in reference to the biparietal diameter (BPD), which is a measurement taken during prenatal ultrasound to assess the size of the fetal head. The biparietal diameter is the distance between the two parietal bones on either side of the fetal skull. It’s an important measurement used to estimate gestational age and monitor fetal growth during pregnancy.
Fetal Well-Being
Doppler Blood Flow Analysis:
Doppler ultrasound is a technique that measures blood flow within the blood vessels. In obstetrics, it is often used to assess blood flow in the umbilical cord and other fetal vessels. Abnormal blood flow patterns can indicate potential issues such as placental insufficiency or fetal distress.
Amniotic Fluid Volume (AFV) Assessment:
The level of amniotic fluid surrounding the fetus is an important indicator of fetal well-being. Too much or too little amniotic fluid can be a sign of problems. An ultrasound can be used to measure the amniotic fluid volume, helping to assess fetal health.
Non-Stress Test (NST):
The non-stress test is a simple and non-invasive test used to evaluate the fetal heart rate in response to the baby’s movements. During the test, the fetal heart rate is monitored using a fetal heart rate monitor. An acceleration in the heart rate when the baby moves is a positive sign, indicating the well-being of the fetus. Because it’s responding to the movement and the heart is beating faster to adjust to the higher demand of oxygen requested by the tissues.
Biophysical Profile (BPP):
The biophysical profile is a comprehensive assessment that combines multiple factors to evaluate fetal well-being. These factors typically include fetal heart rate monitoring (NST), fetal breathing movements, fetal movement, amniotic fluid volume assessment, and fetal muscle tone. Each factor is assigned a score, and the cumulative score helps determine the overall health of the fetus.
Modified Biophysical Profile:
The modified biophysical profile is a variation of the standard BPP that focuses on fewer parameters. It often includes the NST and the assessment of amniotic fluid volume. This streamlined version is sometimes used when a full BPP is not necessary or feasible.
Biophysical Profile (BPP)
There are 5
-Fetal Breathing Movements (2)
-Gross Body Movements (2) can baby move
-Fetal Tone (2) can baby clinch fist
-Reactive Heart Rate (NST) (2)
-Qualitative amniotic fluid volume (AFI) (2)
Breakdown of the components of a Biophysical Profile (BPP)
Here’s the standard scoring breakdown for a
BPP:
Normal: 2 points
Abnormal: 0 points
Biophysical Profile (BPP):
The BPP evaluates the fetal well-being by assessing five different components:
Fetal Breathing Movements:
Normal (Score = 2): 1 or more episodes of fetal breathing movements lasting >20 seconds within 30 minutes. Meaning the baby took at least 20 sec or more in the last 30 min (this = 2, meaning aprovado)
Abnormal (Score = 0): Absent or no episode of fetal breathing movements lasting >20 seconds within 30 minutes.
Gross Body Movements:
Normal (Score = 2): 2 or more discrete body/limb movements within 30 minutes (episodes of continuous movement are considered as a single movement).
Abnormal (Score = 0): Less than 2 episodes of body/limb movements within 30 minutes.
Fetal Tone:
Normal (Score = 2): 1 or more episodes of active extension with return to flexion of fetal limb(s) or trunk (normal tone). Opening and closing of the hand are considered normal tone.
Abnormal (Score = 0): Slow extension with return to partial flexion, movement of a limb in full extension, absent fetal movement, or partially open fetal hand.
Reactive Fetal Heart Rate (FHR):
Normal (Score = 2): 2 or more episodes of acceleration of ≥15 beats per minute (bpm) and of >15 seconds associated with fetal movement within 20 minutes.
Abnormal (Score = 0): 1 or more episodes of acceleration of fetal heart rate of <15 bpm within 20 minutes.
Qualitative Amniotic Fluid Volume (AFV):
Normal (Score = 2): 1 or more pockets of amniotic fluid measuring ≥2 cm in the vertical axis.
Abnormal (Score = 0): Either no pockets of amniotic fluid or the largest pocket measuring <2 cm in the vertical axis.
INTERPRETATION of BPP
8-10 = Normal, Low Risk
4-6 = Suspected Chronic Asphyxia
2 = Strong Suspicion of Asphyxia
8-10: Normal, Low Risk: A BPP score of 8 to 10 points is considered normal and indicates that the baby’s well-being is generally healthy. This range suggests that the components assessed in the BPP, such as fetal movements, breathing, tone, heart rate, and amniotic fluid, are within expected parameters.
4-6: Suspected Chronic Asphyxia: A BPP score of 4 to 6 points indicates a potential concern about the baby’s well-being, specifically related to chronic asphyxia. Asphyxia refers to inadequate oxygen supply to the fetus. A score in this range suggests that some components of the BPP may be abnormal, which could indicate that the baby is experiencing challenges related to oxygenation.
2: Strong Suspicion of Asphyxia: A BPP score of 2 points is indicative of a strong suspicion of asphyxia, suggesting that there are significant concerns about the baby’s well-being and oxygen supply. A score of 2 points implies that several components of the BPP are likely showing abnormalities, indicating potential issues with the baby’s health and oxygenation.
- Amniotic Fluid Index (AFI)
- Amniotic Fluid Volume (AVI)
Measures the vertical depths of the largest pocket of amniotic fluid in all four quadrants surrounding the maternal umbilicus and totaled
Amniotic Fluid Index (AFI):
The Amniotic Fluid Index (AFI) is a measurement used to assess the amount of amniotic fluid present in the uterus during pregnancy. Amniotic fluid is a liquid that surrounds and protects the developing fetus. It also plays a crucial role in maintaining a stable environment for fetal growth and development. The AFI is typically measured using ultrasound.
The AFI is calculated by dividing the uterus into four quadrants and measuring the deepest vertical pocket of amniotic fluid in each quadrant. The measurements from the four pockets are then added together to determine the AFI. This measurement helps healthcare providers assess the volume of amniotic fluid and detect any abnormalities.
Amniotic Fluid Volume (AFV):
“Amniotic Fluid Volume” is a general term that refers to the amount of fluid within the amniotic sac during pregnancy. The amniotic sac is the membrane that surrounds the fetus and contains the amniotic fluid. The term itself doesn’t represent a specific measurement or test like AFI does. Instead, it’s a broader description of the fluid surrounding the fetus.
In summary, the Amniotic Fluid Index (AFI) is a specific measurement used to assess the quantity of amniotic fluid in the uterus during pregnancy, while “Amniotic Fluid Volume” (AFV) is a general term referring to the fluid surrounding the fetus within the amniotic sac. If you’re discussing amniotic fluid levels in a clinical context, you’re likely referring to AFI as the specific measurement used to assess fluid volume.
AFI or AVI measures four quadrants. 5-25 cm is normal.
The amniotic fluid index (AFI) is a measurement that quantifies the amount of amniotic fluid in the uterus. It’s typically measured in centimeters and is used to assess the adequacy of the amniotic fluid level. An AFI of 5-25 cm is generally considered normal. An AFI below 5 cm might indicate oligohydramnios, which is a lower-than-normal level of amniotic fluid, while an AFI above 25 cm could indicate polyhydramnios, which is an excessive amount of amniotic fluid.
Biochemical Assessment.
Procedures to obtain specimens:
Amniocentesis: This is a prenatal diagnostic procedure in which a small amount of amniotic fluid is withdrawn from the amniotic sac surrounding the fetus. It’s typically performed between the 15th and 20th weeks of pregnancy. The amniotic fluid contains cells and biochemical markers that can provide information about the fetus’s genetic makeup, health, and development. Amniocentesis is often used to screen for genetic conditions such as Down syndrome, as well as to detect neural tube defects and certain genetic disorders.
Chorionic Villus Sampling (CVS): CVS is another prenatal diagnostic procedure that involves sampling a tiny piece of tissue from the placenta, specifically the chorionic villi. This procedure is usually done between the 10th and 13th weeks of pregnancy. The chorionic villi have the same genetic information as the fetus and can provide insights into genetic conditions and chromosomal abnormalities.
Maternal Assays: These are blood tests performed on the pregnant mother to assess various markers that can indicate potential issues with the pregnancy. These tests often measure hormone levels, proteins, and other substances in the mother’s blood that might be indicative of certain conditions in the fetus, such as neural tube defects or chromosomal abnormalities. Examples of maternal assays include the multiple marker screen and non-invasive prenatal testing (NIPT).
Percutaneous Umbilical Blood Sampling (PUBS): Also known as cordocentesis, this procedure involves withdrawing a small sample of blood from the umbilical cord. It is typically used in cases where more direct and immediate information about the fetus’s health is needed. PUBS can provide information about blood disorders, infections, and other conditions affecting the fetus’s blood.
AMNIOCENTESIS
-Genetic and chromosomal abnormalities (15- 20 weks)
-Fetal Lung Maturity
-Rh isoimmunization status and severity of hemolytic anemia
-AFP (Alpha Feto Protein) levels which indicate anatomic abnormalities (Fetal Nutrition: AFP is produced by the fetal liver and plays a role in transporting nutrients from the mother’s bloodstream to the developing fetus. It helps ensure that the fetus receives the necessary nutrients for growth and development.)
2 Ways of Measuring the Infant’s Lung Maturity
Lecithin to Sphingomyelin (L/S) Ratio:
The Lecithin to Sphingomyelin (L/S) ratio is a test that assesses the relative levels of two specific types of phospholipids in the amniotic fluid. Phospholipids are important components of surfactant, a substance that lines the alveoli (air sacs) in the lungs and helps reduce surface tension, preventing the alveoli from collapsing. The L/S ratio is calculated by dividing the concentration of lecithin (also known as phosphatidylcholine) by the concentration of sphingomyelin.
2 or More: An L/S ratio of 2 or more is generally indicative of fetal lung maturity and suggests a low risk of infant respiratory distress syndrome (RDS). This means that there is an adequate amount of surfactant in the fetal lungs to support normal breathing after birth.
1.5 or Less: An L/S ratio of 1.5 or less is associated with a higher risk of RDS. A lower ratio indicates that there might be insufficient surfactant present, which could lead to respiratory difficulties for the newborn.
Phosphatidylglycerol (PG):
Phosphatidylglycerol is another component of surfactant, and its presence in the amniotic fluid is an indicator of fetal lung maturity.
Presence of PG: The presence of phosphatidylglycerol in the amniotic fluid is a positive sign of fetal lung maturity. It suggests that the fetal lungs are producing surfactant, which is crucial for proper lung function after birth.
ACOG recommendations as of August 2017
- from the American College of Obstetricians and Gynecologists (ACOG) as of August 2017 regarding the administration of antenatal corticosteroids (also known as betamethasone or BMZ) for fetal lung maturation in cases of anticipated preterm birth. These recommendations aim to reduce the risk of respiratory complications in premature infants.
Timing of Delivery and Fetal Lung Maturity:
ACOG’s recommendation states that if a patient is in a situation where delivery is indicated, it should be carried out regardless of fetal lung maturity status. In other words, if there is a medical reason for delivery, the need for delivering the baby takes precedence over assessing fetal lung maturity.
Administration of BMZ Before 34 Weeks:
If a patient is less than 34 weeks pregnant and is facing imminent delivery within the next 7 days, and if they haven’t received antenatal corticosteroids (BMZ) within the last 14 days, then ACOG recommends the administration of BMZ to promote fetal lung maturation.
Administration of BMZ Between 34 and 36.6 Weeks:
If a patient is between 34 and 36.6 weeks pregnant and is at risk of preterm birth within the next 7 days, and they either haven’t received BMZ before or their prior course was more than 14 days ago, then ACOG recommends considering the administration of BMZ.
Complications
Less than 1%. Chorionic Villus Sampling (CVS)
10-12 weeks sometimes 13
Complications of CVS for the Mother:
Infection: Any medical procedure carries a risk of infection, but the risk of infection after CVS is relatively low.
Hemorrhage: There’s a small chance of bleeding after the procedure due to the needle insertion. This is usually minimal and self-limited.
Damage to Bladder or Intestines: Although extremely rare, there’s a possibility of accidental damage to nearby organs during the procedure.
Miscarriage: The risk of miscarriage is a concern with any invasive prenatal procedure. However, modern techniques have reduced this risk significantly, and the risk associated with CVS is generally considered to be less than 1%.
Preterm Labor (PTL): In some cases, CVS might trigger contractions that could lead to preterm labor. However, the incidence of this complication is low.
Leakage of Amniotic Fluid (AF): The risk of amniotic fluid leakage is minimal, but it’s still important to monitor for this potential complication.
Rh Sensitization: This refers to the development of antibodies in the mother’s blood that could affect subsequent pregnancies. This risk is relatively low and can be managed with appropriate medical interventions.
Complications of CVS for the Baby:
Death: While extremely rare, there’s a very small chance that the procedure could lead to fetal demise.
Hemorrhage: Similar to the risk in mothers, there’s a low risk of bleeding for the baby due to the needle insertion.
Infection: The risk of infection affecting the baby is generally low.
Chorionic Villus Sampling (CVS)
10-12 weeks.
Nursing care
Explain Procedure and provide comfort measures and emotional support
Fetal Monitoring
Patient teaching:
Report leaking fluid
Abdominal pain
Bleeding
Decreased Fetal movement
Fever
Rhogham to RH- women
Fetal Assessment via Electronic Fetal Monitoring
Non-Stress Test (NST):
The Non-Stress Test is a relatively simple and non-invasive procedure that monitors the fetal heart rate and its variability in response to the natural movements of the fetus. It’s typically performed during the third trimester of pregnancy and involves placing two monitors on the mother’s abdomen:
Fetal Heart Rate Monitor: This monitor records the fetal heart rate over a specific period, usually around 20 to 30 minutes. It detects accelerations in the fetal heart rate that are associated with fetal movement.
Tocodynamometer: This monitor measures uterine contractions, which can help correlate any changes in the fetal heart rate with contractions.
During the test, the healthcare provider assesses the fetal heart rate patterns for baseline variability and the presence of accelerations, which are positive signs of fetal well-being. A reactive NST is characterized by the presence of a certain number of accelerations within a specified time frame, indicating that the fetus is receiving an adequate oxygen supply.
Contraction Stress Test (CST or OST):
The Contraction Stress Test, also known as the Oxytocin Stress Test (OST), is a more intensive test used to assess the ability of the fetus to withstand the stress of labor contractions. This test is usually reserved for cases where there might be concerns about the fetus’s oxygen supply during labor.
The CST involves stimulating uterine contractions, either naturally through nipple stimulation or artificially using a medication called oxytocin. The goal is to simulate the stress of labor contractions and observe the fetal heart rate response. Similar to the NST, monitors are placed on the mother’s abdomen to measure both fetal heart rate and uterine contractions.
Interpretation of the CST results involves evaluating the fetal heart rate patterns in response to contractions. A negative CST result shows that the fetus’s heart rate remains relatively stable during contractions, indicating a reassuring sign of fetal well-being. A positive CST result, on the other hand, indicates that the fetal heart rate decelerates significantly during contractions, which could suggest inadequate oxygen supply and might require further evaluation.
Fetal Assessment via Electronic Fetal Monitoring
Electronic Fetal Monitoring (EFM) is a medical procedure used to assess the well-being of a fetus during pregnancy and labor. It involves the use of electronic devices to monitor the fetal heart rate and uterine contractions. EFM is commonly used to determine the timing of childbirth for women who are at risk for various complications, including uteroplacental insufficiency (UPI). Uteroplacental insufficiency refers to a condition where the placenta is not providing enough oxygen and nutrients to the fetus.
Here’s how the process of fetal assessment via Electronic Fetal Monitoring might work:
Identification of High-Risk Patients: Healthcare providers identify pregnant women who are at high risk for uteroplacental insufficiency. These risk factors might include conditions like preeclampsia, gestational diabetes, chronic hypertension, intrauterine growth restriction (IUGR), and certain maternal medical conditions.
Gestational Age: The timing of fetal assessment via EFM can vary depending on the gestational age of the fetus. In the case mentioned (women at risk for UPI), assessment is suggested around 32-34 weeks of pregnancy. This is a critical time as the fetus is nearing term and any signs of distress need to be closely monitored.
Frequency of Monitoring: High-risk patients are typically monitored 1-2 times a week using EFM. This regular monitoring allows healthcare providers to closely track the fetal heart rate and uterine contractions and detect any potential issues promptly.
Electronic Fetal Monitoring: During the EFM procedure, two sensors are typically used:
Fetal Heart Rate Monitor: This sensor is placed on the mother’s abdomen to monitor the fetal heart rate. Changes in the fetal heart rate pattern can indicate distress or potential oxygen deprivation.
Uterine Contraction Monitor: Another sensor measures the frequency and strength of uterine contractions. This helps assess the stress placed on the fetus during contractions.
Data Interpretation: The data from EFM is continuously displayed on a monitor, allowing healthcare providers to observe the fetal heart rate and contractions in real-time. They will look for patterns and changes that could indicate fetal distress. There are different patterns that may be concerning, such as decreased variability in the fetal heart rate, late decelerations (heart rate drops after contractions), and other irregularities.
Intervention: If the EFM indicates any signs of fetal distress or compromised well-being, the healthcare team will intervene accordingly. This could involve adjusting the mother’s position, providing oxygen, increasing intravenous fluids, or considering more urgent interventions such as an emergency cesarean section.
It’s important to note that while EFM is a valuable tool for fetal assessment, it is not without limitations and can sometimes result in false positives or false negatives. It requires skilled interpretation by healthcare providers who are experienced in understanding fetal heart rate patterns.
Fetal Heart Monitoring
NON-STRESS TEST:
- Evaluate FHR during movement.
- Reactive/Nonreactive
- Reactive = 2 Accelerations in 20 minutes.
- Accelerations are FHR equal or greater than 15 BPM over baseline lasting 15 seconds or more.
Reactive NST Example:
In a reactive NST, the fetal heart rate shows the desired pattern of accelerations in response to fetal movement.
During a 20-minute monitoring period, the following pattern is observed:
Acceleration 1: Fetal heart rate increases by 25 BPM above the baseline of 140 BPM for 20 seconds in response to fetal movement.
Acceleration 2: Fetal heart rate increases by 30 BPM above the baseline of 150 BPM for 25 seconds in response to another fetal movement.
Result: This NST is considered reactive because it meets the criteria of having at least two accelerations of 15 BPM or more above the baseline, each lasting for at least 15 seconds, within the 20-minute monitoring period. A reactive NST indicates that the fetus is responding appropriately to its movements and is likely receiving adequate oxygen and nutrients.
Nonreactive NST Example:
In a nonreactive NST, the fetal heart rate does not show the desired pattern of accelerations in response to fetal movement.
During a 20-minute monitoring period, the following pattern is observed:
Minimal or no accelerations in the fetal heart rate are observed in response to fetal movements.
The baseline heart rate remains relatively stable around 130 BPM.
Result: This NST is considered nonreactive because it does not meet the criteria of having at least two accelerations of 15 BPM or more above the baseline, each lasting for at least 15 seconds, within the 20-minute monitoring period. A nonreactive NST may raise concerns about fetal well-being and might prompt further assessment and evaluation to determine the underlying cause of the nonreactive result.
CONTRACTION STRESS TEST. To see if the baby can handle the contractions in the future during delivery and still be able to breath while this is happening. Negative is good (A negative CST result means that there are no significant decelerations in the fetal heart rate during contractions. )
Contraction Stress Test (CST): A CST is a diagnostic test conducted during pregnancy to evaluate how the fetus will tolerate the stress of labor contractions. It helps determine if the fetus is receiving enough oxygen during contractions.
Endogenous Oxytocin: Oxytocin is a hormone naturally produced by the body, often referred to as the “love hormone” because it plays a role in social bonding and childbirth. In the context of a CST, endogenous oxytocin refers to the oxytocin naturally produced by the mother’s body during contractions.
Exogenous Oxytocin: Exogenous oxytocin refers to oxytocin that is administered externally, usually through medication. This can be done to induce or augment labor contractions during the CST or other labor-related procedures.
FHT (Fetal Heart Tracing): FHT refers to monitoring the fetal heart rate, which can provide important information about the well-being of the fetus. Changes in the fetal heart rate can indicate how the fetus is responding to various factors, including contractions.
Decelerations: Fetal heart rate decelerations are temporary drops in the fetal heart rate. They can be categorized as early decelerations, late decelerations, and variable decelerations. The timing and pattern of decelerations provide insights into fetal well-being.
Based on your provided information, it seems you’re discussing the results of the Contraction Stress Test and their interpretation:
Negative Result: A negative CST result means that there are no significant decelerations in the fetal heart rate during contractions. Specifically, there are no decelerations observed with at least three uterine contractions (UCs) lasting 40-60 seconds each in a 10-minute period. This is generally considered a reassuring sign, indicating that the fetus is tolerating the stress of contractions well. Meaning that even if the baby is under stress (contractions) he can still receive oxygen and keep a constant heart rate.
Positive Result: A positive CST result indicates that decelerations in the fetal heart rate are observed with 50% or more of the uterine contractions. This could be a sign that the fetus is not receiving enough oxygen during contractions, which might raise concerns about the fetus’s well-being.
Contraindications of CST
PTL (Preterm Labor): Preterm labor refers to labor that starts before 37 weeks of pregnancy. Performing a CST in the presence of preterm labor might not be advisable, as the contractions induced during the test could potentially worsen the existing condition and lead to premature birth.
Placenta Previa: Placenta previa is a condition where the placenta partially or completely covers the cervix. Due to the risk of bleeding associated with placenta previa, performing a CST could potentially trigger bleeding or other complications.
Cervical Insufficiency: Cervical insufficiency, also known as an incompetent cervix, is a condition where the cervix begins to dilate and efface (thin out) prematurely, often leading to preterm labor. In this situation, performing a CST could further contribute to cervical changes and potentially lead to complications.
Multiple Gestation: When a pregnant person is carrying multiple fetuses (twins, triplets, etc.), there is an increased risk of preterm labor and other complications. Inducing contractions during a CST might pose additional risks in these cases.
Previous C/S (Previous Cesarean Section): If a person has had a previous cesarean section (C-section), there could be scar tissue on the uterus. Inducing contractions during a CST might put stress on the uterine scar, potentially increasing the risk of uterine rupture.
32 through 40 slides
SPONTANEOUS ABORTION
Threatened Abortion: This term is used when a pregnant person experiences vaginal bleeding and possibly mild cramping, but the cervix is still closed, and the pregnancy remains viable. In many cases, the bleeding stops, and the pregnancy continues without further complications.
Inevitable Abortion: Inevitable abortion occurs when vaginal bleeding and cramping become more pronounced, and there may be signs that the cervix is opening. This suggests that a miscarriage is likely to occur, and there is no way to prevent it.
Incomplete Abortion: An incomplete abortion happens when only part of the products of conception (fetus, placenta, etc.) are expelled from the uterus. This can lead to persistent bleeding and infection risks, and medical intervention may be needed to remove the remaining tissue.
Complete Abortion: In a complete abortion, all of the products of conception are expelled from the uterus. The bleeding and cramping typically subside after this occurs.
Missed Abortion: A missed abortion (also called a missed miscarriage) refers to a situation where the fetus has died, but the body has not yet recognized the loss. There might be no symptoms, and the pregnancy might continue without fetal development. Medical intervention is often required to manage the situation.
Recurrent (Habitual) Abortion: Recurrent or habitual abortion refers to the occurrence of multiple consecutive miscarriages. If a person experiences three or more consecutive miscarriages, it’s considered habitual, and medical evaluation is often conducted to identify potential underlying causes.
Sepsis: Sepsis is a severe response to infection that can lead to tissue damage, organ failure, and even death. In the context of miscarriage, sepsis can occur if an infection develops after a miscarriage and is not promptly treated.
SPONTANEOUS ABORTIONSigns and Symptoms. Dependent on duration of pregnancy
Spontaneous abortion, commonly known as a miscarriage, refers to the natural loss of a pregnancy before the 20th week of gestation. It occurs when the fetus and other products of conception are expelled from the uterus due to various factors, often before the pregnancy reaches a point where the fetus is viable outside the womb. Spontaneous abortion can happen for a variety of reasons, including genetic abnormalities, hormonal imbalances, uterine abnormalities, infections, and more.
Vaginal Bleeding: Vaginal bleeding is a common symptom of miscarriage. It can range from light spotting to heavy bleeding. The color of the blood can also vary, from bright red to brownish. In the early stages of pregnancy, vaginal bleeding might be the only noticeable symptom of a miscarriage.
Abdominal Pain: Abdominal pain is another common symptom associated with miscarriage. The pain might feel like cramps and can vary in intensity. The pain might be similar to menstrual cramps in the early stages of pregnancy.
Cramping: Cramping is often felt along with abdominal pain and can be quite uncomfortable. The intensity and duration of cramps can vary.
Pelvic Pressure: As the pregnancy progresses and the uterus expands, you might feel increased pressure in the pelvic region. This pressure can be more pronounced during a miscarriage.
Low Back Pain: Low back pain is also a symptom that some individuals experience during a miscarriage. It can be similar to the back pain experienced during menstruation
SPONTANEOUS ABORTIONRisk Factors:
Congenital Malformations: Congenital malformations or abnormalities in the developing fetus can increase the risk of miscarriage, particularly during the first trimester of pregnancy. These abnormalities can affect the fetus’s development and viability, leading to a natural loss of pregnancy.
Maternal Infections: Infections during pregnancy can pose a risk to both the mother and the developing fetus. Some infections, such as certain types of bacterial or viral infections, can increase the risk of miscarriage due to their impact on fetal development.
Maternal Endocrine Problems: Hormonal imbalances or endocrine disorders in the mother can affect the pregnancy’s progression and increase the risk of miscarriage. Hormones play a crucial role in maintaining a healthy pregnancy.
AMA (Advanced Maternal Age): Advanced maternal age, often defined as being 35 years or older, is associated with an increased risk of miscarriage. This increased risk is thought to be due to factors such as higher rates of genetic abnormalities in pregnancies of older individuals.
Previous Loss: Having a history of previous miscarriages can increase the risk of experiencing another miscarriage. Recurrent miscarriages might be indicative of underlying medical conditions that need to be addressed.
SPONTANEOUS ABORTION(not induced by doctor) Management
Bedrest and Fluids (Threatened): In cases of threatened abortion, where there is vaginal bleeding but the cervix is closed and the pregnancy is still viable, healthcare providers might recommend bed rest and increased fluid intake to reduce stress and pressure on the body.
D & C (Dilation and Curettage (cuillère=scoop out)) or Suction Curettage: A D & C procedure involves dilating the cervix and using surgical instruments to remove the remaining contents of the uterus after a miscarriage. This might be recommended in cases of incomplete abortion or if there are concerns about infection.
D & E (Dilation and Evacuation): In the second trimester, a D & E procedure might be performed if the pregnancy loss occurs later on. This procedure involves dilation of the cervix and evacuation of the uterine contents.
Antibiotics (Missed, Septic): Antibiotics might be prescribed if there is an infection associated with the miscarriage (septic miscarriage) or if there are concerns about infection following a missed abortion.
Misoprostol: Misoprostol is a medication that can be used to induce contractions and help expel the contents of the uterus after a miscarriage. It’s often used as an alternative to surgical procedures, especially in cases of incomplete or missed abortion.
Pain Medications: Pain medications might be prescribed to help manage the discomfort or pain associated with the miscarriage and its aftermath.
RhoGAM (Rh-): RhoGAM is a medication given to Rh-negative pregnant individuals to prevent the development of antibodies that could harm future pregnancies. It might be recommended after a miscarriage if there’s a risk of Rh sensitization.
Dialation and Curettage
- Dilation (D): The cervix, the narrow passage that connects the vagina to the uterus, needs to be dilated or widened to create access to the uterine cavity. This is typically done using special dilators, which gradually increase in size to gently expand the cervix.
- Curettage (C): Curettage involves the removal of tissue from the inner lining of the uterus. A curette, a spoon-shaped surgical instrument, is used to carefully scrape away the tissue lining. This can include removing abnormal tissue growth, uterine polyps, or, in the context of a miscarriage, the products of conception that remain in the uterus after the natural loss of a pregnancy.
D&C might be performed for various reasons, including:
Miscarriage Management: In cases of incomplete miscarriage, where not all pregnancy tissue is expelled naturally, a D&C might be performed to remove the remaining tissue and reduce the risk of infection or complications.
Diagnosis and Treatment: D&C can be used to diagnose and treat conditions such as abnormal uterine bleeding, uterine polyps, endometrial hyperplasia (excessive growth of the uterine lining), or certain types of precancerous or cancerous conditions.
Investigation: If a healthcare provider suspects an abnormality, such as during certain diagnostic procedures like hysteroscopy, they might perform a D&C to obtain tissue samples for further examination.
Induced Therapeutic Abortion
EAB (Elective Abortion): EAB stands for “Elective Abortion.” This refers to the purposeful interruption of a pregnancy for non-medical reasons, typically by choice of the pregnant individual. EAB is often chosen when the pregnancy is unwanted, and there are no medical indications for terminating the pregnancy. The decision to undergo an elective abortion is a personal and private one, and it’s made based on a variety of individual, social, and ethical factors.
TAB (Therapeutic Abortion): TAB stands for “Therapeutic Abortion.” This type of abortion is carried out for medical reasons, either for the health of the pregnant individual or due to fetal disorders. There are two main categories within therapeutic abortion:
Maternal Disorders: In cases where continuing the pregnancy poses a serious risk to the health or life of the pregnant person, a therapeutic abortion might be recommended. This could be due to underlying health conditions or complications that could be aggravated by the pregnancy.
Fetal Disorders: Therapeutic abortion might also be considered if the fetus has been diagnosed with severe abnormalities or disorders that are incompatible with life or could lead to serious health challenges after birth.
slide 47-48
A 2012 study of more than 9,000 women found that when women got no-cost birth control, the number of unplanned pregnancies and abortions fell by between 62 and 78 percent.
.
Since Roe vs. Wade
New Supreme Court decision leaves us in uncharted
territory.
Abortion Procedure:Counseling
Regardless of personal views on abortion, nurses who provide care to women seeking abortion have an ethical responsibility to counsel women about their options and to make appropriate referrals
Counseling
- Respectful, non-judgmental communication
- What the client can expect before, during and after the procedure
- Clear instruction on after care and complications to report
- Risks and benefits of what is available
- Confirmation there is no coercion in the decision
- Where to go for follow up care
- Pain management
- Available support (eg. Post counseling)
- Contraception information to prevent further pregnancy including the option for LARC’s at the time of the procedure (Long-Acting Reversible Contraceptives (LARC):
LARC methods are highly effective, reversible contraception options that require minimal user intervention. They include:
IUDs: (intrauterine device) Hormonal or copper-based IUDs can prevent pregnancy for several years. They are inserted into the uterus by a healthcare provider.
Implants: A small rod is inserted under the skin, releasing hormones to prevent pregnancy for several years.)
H&P. History and Physical
- Assess for co-morbidities and possible contraindications to any procedure
- Confirm IUP (as opposed to ectopic)
- Confirm gestational age (LMP)
- Rh status (Rhogam prophylaxis within 72 hours if needed)
Medical Abortions
medical abortions, which are non-surgical methods for terminating pregnancies. Here’s an explanation of the points you’ve mentioned:
Available Time Frame: In the US, medical abortions are typically available for pregnancies up to nine weeks after the last menstrual period (LMP). 2 months and 1 week
Methods:
Methotrexate and Misoprostol: This combination is used for pregnancies up to seven weeks after LMP. Methotrexate interferes with cell reproduction by blocking folic acid metabolism. Misoprostol is used later to cause uterine contractions and empty the uterus.
Misoprostol Alone: Misoprostol can be used alone for pregnancies up to ten weeks after LMP. It stimulates uterine contractions, leading to the expulsion of pregnancy tissue.
Mifepristone (RU-486): Mifepristone, also known as RU-486, is used up to ten weeks after LMP. It blocks the hormone progesterone, which is essential for maintaining pregnancy. The subsequent use of misoprostol causes uterine contractions to expel the pregnancy.
Complications: Medical abortions are generally considered safe with a low rate of complications. However, potential side effects and risks include heavy bleeding, cramping, nausea, vomiting, diarrhea, and incomplete abortion requiring further intervention.
Surgical Abortions : Dilation and Curettage (D&C) 14-16 w
- A hollow curette (tube) is inserted into the uterus. Suction is applied to empty the uterus.
- An instrument called a curette is inserted and scrapes the lining of the utuerus.
***Used up to 14-16 weeks
Surgical Abortions :Dilation and Evacuation (D&E)
After 14 weeks
Dilators
Suction Catheter
Possibly other instruments
Expected Side Effects
- Bleeding
- Cramping
- Less frequent: Nausea, Vomiting, diarrhea, weakness
Complications of surgical abortions
Need for Aspiration (Medical): Aspiration (suction) is a procedure used in medical abortion and involves using suction to remove pregnancy tissue from the uterus. Sometimes, incomplete abortion might require an additional aspiration procedure to remove remaining tissue.
Uterine Perforation (Aspiration/D&E): During procedures like aspiration or dilation and evacuation (D&E), there is a slight risk of unintentional perforation of the uterine wall. This can happen if the instruments penetrate too deeply. If uterine perforation occurs, further medical attention might be required.
Cervical Laceration (Aspiration/D&E): During procedures involving dilation of the cervix (such as aspiration or D&E), there is a small risk of cervical laceration (tearing). This can occur if the cervix is not dilated properly or if instruments are inserted too forcefully.
Cervical insufficiency or Recurrent Premature Dilation of the Cervix
Cervical insufficiency, also known as recurrent premature dilation of the cervix, is a condition where the cervix begins to dilate and efface (thin out) prematurely during the second trimester of pregnancy, typically between 16 to 24 weeks. This can lead to preterm labor and delivery, often resulting in miscarriage or premature birth. Here’s more information about cervical insufficiency:
Symptoms and Diagnosis:
Cervical insufficiency is often characterized by passive and painless dilation of the cervix without contractions or significant discomfort.
It’s diagnosed based on a history of recurrent second-trimester pregnancy losses or preterm deliveries.
Risk Factors:
Women who have a history of cervical trauma (such as previous surgical procedures on the cervix) or structural abnormalities of the cervix might be at higher risk for cervical insufficiency.
Multiple miscarriages or preterm births can also be an indicator.
Management and Treatment:
- Recurrent passive and painless dilation of the cervix during the 2nd Trimester. Doctors diagnose cervical insufficiency based on a person’s history of having multiple miscarriages or giving birth too early.
- Dx based on history
Cervical insufficiency or Recurrent Premature Dilation of the Cervix. Risk Factors:
Congenital Risk Factors:
Presence of Bicornuate Uterus: A bicornuate uterus is a congenital condition where the uterus is divided into two distinct cavities. This structural abnormality can increase the risk of cervical insufficiency.
Exposure to DES (Diethylstilbestrol): DES is a synthetic estrogen that was given to some pregnant women between the 1940s and 1970s. Women exposed to DES in utero might be at increased risk of cervical insufficiency.
2. Acquired Risk Factors:
Multiple Gestation: Carrying more than one fetus (twins, triplets, etc.) can put extra pressure on the cervix and increase the risk of cervical insufficiency.
Infection: Certain infections can weaken the cervix and contribute to its premature dilation.
Trauma: Previous surgeries, procedures, or trauma to the cervix can weaken its structure and make it more prone to premature dilation.
3. Hormonal Risk Factors:
Relaxin Hormone: Relaxin is a hormone that helps soften and relax tissues in the body, including the cervix, during pregnancy. High levels of relaxin might contribute to cervical insufficiency.
Management: Medical . Cervical insufficiency or Recurrent Premature Dilation of the Cervix
- Bedrest:
Bedrest involves limiting physical activity and spending more time resting in a horizontal position.
The goal is to reduce pressure on the cervix and minimize the risk of further dilation.
2. Pelvic Rest:
Pelvic rest means avoiding sexual intercourse and refraining from any activities that could put stress on the pelvic area.
This approach aims to reduce the risk of irritation or additional strain on the cervix.
3. Anti-Inflammatory Medications:
Anti-inflammatory medications might be prescribed to manage any inflammation or discomfort that might be contributing to cervical changes.
These medications can help alleviate symptoms and support the cervix’s stability.
4. Progesterone:
Progesterone supplementation might be recommended to help maintain the integrity of the cervix and prevent further dilation.
Progesterone is a hormone that plays a crucial role in supporting pregnancy and maintaining the uterine environment.